Bitnile Holdings Announces Additional Investment In Alzamend From Completion Of Phase 1 First-In-Human Clinical Trial For Al001 Treatment Of Dementia Related To Alzheimer’s
Apr 28, 2022•about 3 years ago
Description
BitNile Holdings, Inc. (NYSE American: NILE), a diversified holding company (“BitNile” or the “Company”) announced today its wholly owned subsidiary, Digital Power Lending, LLC (“DP Lending”) has made an additional investment in Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a related party and early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders.